Platelet transfusion effects on blood vessel health in intensive care
Part of Blood & lymphatic clinical trials.
This study looks at how giving platelets to patients with low platelet counts affects the health of small blood vessels. It aims to see if platelet transfusions help improve blood flow and vessel function in critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the intensive care unit (ICU).
- You have low platelet counts and need a platelet transfusion to prevent bleeding.
- You have not had a platelet or red blood cell transfusion in the last 24 hours.
- You are not bleeding actively and do not need an urgent red blood cell transfusion.
- You are not under guardianship or conservatorship, and you do not have significant swelling in your arms or legs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This trial tests whether umbilical cord blood can help raise platelet levels in people whose platelets drop after cancer treatment. If it works, it might reduce the need for platelet transfusions and lower bleeding risk.
This study is looking at how well a special method works that treats platelets to kill germs (pathogens) before they are given to patients. It may be a good fit if you need regular platelet transfusions because your body doesn't make enough platelets.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.